© 2021 Journal of Pharmacy & Pharmacognosy Research, 9 (3), 333-343, 2021
ISSN 0719-4250
http://jppres.com/jppres
Original Article
Khat-drug interactions: A systematic review
[Interacciones khat-medicamentos: una revisión sistemática]
Nabil Ahmed Albaser1,2*, Abdel-Wahab H. Mohamad2, Mohammed Amood AL-Kamarany3
1Pharmacology
Department, Faculty of Medical Sciences, Pharmacy, AL Razi University, Sana'a, Yemen.
of Therapeutics, Pharmacy College, National Ribat University, Khartoum, Sudan.
3Department of Pharmacy Practice, Faculty of Clinical Pharmacy, Hodeidah University, Hodeidah, Yemen.
*E-mail: nabil4@yemen.net.ye; nabilalbaser2020@gmail.com
2Department
Abstract
Resumen
Context: Consumption of khat leaves has been disseminated worldwide
with the migration of its users from Arabia and Africa. Despite
numerous reports regarding the associations of khat chewing with
serious health impacts, a significant number of people worldwide uses
khat daily, especially in its origin countries. The risk of coadministration of khat and drugs (prescription and over the-counter
medications) is high among these individuals, leading to increase
probability of adverse khat-drug interactions. The likelihood of khatdrug interactions could be higher than drug-drug interactions because
drugs usually contain single chemical entities while almost all herbs
(including khat) contain mixtures of pharmacologically active
constituents.
Contexto: El consumo de hojas de khat se ha difundido en todo el mundo
con la migración de sus usuarios desde Arabia y África. A pesar de los
numerosos informes sobre las asociaciones de masticar khat con graves
impactos en la salud, un número significativo de personas en todo el
mundo usa khat a diario, especialmente en sus países de origen. El
riesgo de coadministración de khat y medicamentos (medicamentos
recetados y de venta libre) es alto entre estos individuos, lo que aumenta
la probabilidad de interacciones adversas entre ellos. La probabilidad de
interacciones entre el khat y el fármaco podría ser mayor que la de las
interacciones entre fármacos porque los fármacos suelen contener
entidades químicas únicas, mientras que casi todas las hierbas (incluido
el khat) contienen mezclas de componentes farmacológicamente activos.
Aims: To review the literatures on how khat interacts with some drugs
and whether it is favorable or not.
Objetivos: Revisar la literatura sobre cómo interactúa el khat con algunas
drogas y si es favorable o no.
Methods: The study was conducted as a systematic review. The
electronic literature searches were made in Google search engine to
access publications from databases like PubMed, Google Scholar, and
Cochrane using the keywords ‘khat’, ‘Catha edulis’ in combination with
the terms ‘drug interaction’, ‘adverse-effects’, ‘side effects’, ‘adverse
drug reaction’, ‘safety’, and ‘toxicity’ to identify relevant articles.
Métodos: El estudio se realizó como una revisión sistemática. Las
búsquedas de literatura electrónica se realizaron en el motor de
búsqueda de Google para acceder a publicaciones de bases de datos
como PubMed, Google Scholar y Cochrane utilizando las palabras clave
‘khat’, ‘Catha edulis’ en combinación con los términos 'interacción
farmacológica', 'efectos adversos', 'efectos secundarios', 'reacción adversa
a un fármaco', 'seguridad' y 'toxicidad' para identificar artículos
relevantes.
Results: A total of 250 articles was identified, and these articles were
checked in terms of title, abstract, and content according to inclusion
and exclusion criteria. Finally, 18 articles were included in the study.
The khat use significantly interact with most drugs and may cause
unpredictable pharmacological sequences.
Conclusions: Healthcare providers suggest patients` khat abstinence
during medication process. Future studies need to investigate the khatclinical drugs interactions especially with chronic used drugs.
Keywords: Catha edulis; cathinone; drug interactions; drug metabolizing
enzymes; khat.
Resultados: Se identificó un total de 250 artículos y se verificaron estos en
términos de título, resumen y contenido según los criterios de inclusión
y exclusión. Finalmente, 18 artículos fueron incluidos en el estudio. El
uso de khat interactúa significativamente con la mayoría de los fármacos
y puede provocar secuencias farmacológicas impredecibles.
Conclusiones: Los proveedores de atención médica recomiendan la
abstinencia de khat de los pacientes durante el proceso de medicación.
Los estudios futuros deben investigar las interacciones entre el khat y los
fármacos, especialmente con los fármacos de uso crónico.
Palabras Clave: Catha edulis; catinona; enzimas metabolizadoras de
fármacos; interacciones con fármacos; khat.
ARTICLE INFO
Received: September 30, 2020.
Received in revised form: December 25, 2020.
Accepted: December 29, 2020.
Available Online: January 6, 2021.
_____________________________________
Albaser et al.
INTRODUCTION
Consumption of khat leaves has been disseminated worldwide with the migration of its users
from Arabia and Africa (Lim et al., 2019). During
the past few decades khat chewing has gained
global prominence as the result of migration. Khat
already has a global market and a recognized economic value comparable to other crops such as tea,
coffee, and cacao. The khat trade has a complex
distribution network. As a consequence of rapid
and relatively inexpensive air transportation, khat
has been reported in Great Britain, Netherlands,
Canada, Australia, New Zealand, USA and even in
Hungary (Abbott et al., 2019). It is estimated that
20 million people worldwide chew khat leaves
regularly to enjoy its psychostimulant effects
(Balint et al., 2009). In Yemen, khat-chewing is a
widespread habit; approximately 80–85% of male
and 10–60% of female adults in Northern Yemen
chew khat at least once a week (Bogale et al., 2016).
Despite numerous reports regarding the associations of khat chewing with serious health impacts,
a significant number of people worldwide use
khat on daily basis, especially in its origin countries (Lim et al., 2019). The risk of coadministration of khat and clinical drugs (prescription and over the-counter medications) (Abbott et al., 2019) is high among these individuals,
leading to increased probability of adverse khatdrug interactions. The likelihood of khat-drug interactions could be higher than drug-drug interactions because drugs usually contain single chemical entities while almost all herbs (including khat)
contain mixtures of pharmacologically active constituents (Wondemagegn et al., 2017). Therefore,
herb-drug interactions may pose a potential risk
for patients on medication with narrow therapeutic range drugs to cause serious clinical consequences (Bedada et al., 2018). Khat-drug interactions probably alter the drug’s pharmacokinetics
and/or pharmacodynamics, and hence resulting in
adverse drug interactions or decreased treatment
efficacy. Clinical drug typically contains single
chemical moiety, whereas most of herbal drugs
(even single herb drug) contains more than one
http://jppres.com/jppres
Khat-drug interactions: A systematic review
chemical moiety having pharmacological activity.
Khat is taken by healthy individuals as well as
patients with medical conditions including diabetes mellitus, cancer, mental illness and other acute
or chronic medical conditions. Khat-drug interaction can occur through either pharmacokinetic or
pharmacodynamics mechanisms. Khat can alter
the oral bioavailability of the co-administered clinical drugs, which can result in either synergistic/additive (positive) or antagonistic (negative)
effect on its action.
Catha edulis (Vahl) Endl. (Celastraceae), commonly known as “khat,” is a tree or a large shrub that
is endogenously found in Arab peninsula specially
in Yemen, and some African countries such as
Ethiopia and Kenya, and in western Asia
(Hussain, 2011). Its young buds and tender twigs,
young shoots or stem tips are chewed to attain a
state of euphoria and stimulation. Khat is an evergreen shrub, which is cultivated as a bush or small
tree. The leaves have an aromatic odor. The taste is
astringent and slightly sweet. The plant is seedless
and hardly growing in a variety of climates and
soils. Khat can be grown in droughts where other
crops have failed and also at high altitudes. Khat is
harvested throughout the year and planting is
staggered to obtain a continuous supply. The
leaves are chewed to release the active constituents
slowly to be ingested with saliva. Chewing sessions can last from 3 to 7 h (Cupp, 1999; AlJuhaishi et al., 2012). Khat contains more than forty
alkaloids, glycosides, tannins, amino acids, vitamins, and minerals. The environmental and climate conditions determine the chemical profile of
khat leaves. In Yemen, about 44 different types of
khat exist originating from different geographic
areas of the country (Izzo, 2012; Bedada et al.,
2015). The phenylalkylamines and the cathedulins
are the major alkaloids (Table 1). The cathedulins
are based on a polyhydroxylated sesquiterpene
skeleton and are basically polyesters of euonyminol. Recently, 62 different cathedulins from
fresh khat leaves were characterized (Patel, 2000).
The khat phenylalkylamines comprise cathinone
[S-(–)-cathinone], and the two diastereoisomers
J Pharm Pharmacogn Res (2021) 9(3): 334
Albaser et al.
Khat-drug interactions: A systematic review
Table 1. Summary of different classes of alkaloids in khat leaves (Nyongesa, 2013).
Alkaloids in khat
Phenylalkylamines
Cathedulins
Phenylpropylamines
Phenylpentenylamines
High molecular mass (1000-1170 Da)
Phenylpropanonamine
Phenylpropanolamine
Pseudomerucathine
Medium molecular mass (765-891 Da)
(-) Cathinone
Norephedrine
Merucathinone
Low molecular mass (595-700 Da)
(+) Cathine
Merucathine
cathine [1S, 2S-(+)- norpseudoephedrine or (+)norpseudoephedrine] and norephedrine [1R,2S(–)-norephedrine]. These compounds are structurally and pharmacologically related to amphetamine and noradrenaline. The plant contains the (-)enantiomer of cathinone only (Al-Juhaishi et al.,
2012). Thus, the naturally occurring S-(–)cathinone has the same absolute configuration as
S-(+)-amphetamine. Cathinone is mainly found in
the young leaves and shoots. During maturation,
cathinone is metabolized to cathine [(+)norpseudoephedrine] and (-)-norephedrine. The
leaves contain [(+)-norpseudoephedrine] and (-)norephedrine in a ratio of approximately 4:1 (AlJuhaishi et al., 2012). Other phenylalkylamine alkaloids found in khat leaves are the phenylpentenylamines merucathinone, pseudomerucathine and
merucathine. These compounds seem to contribute
less to the stimulant effects of khat (Cupp, 1999;
Lim et al., 2019). Almost all khat pharmacological
properties are attributed to cathinone, which is an
alkaloid that decomposes rapidly in vivo by metabolism into nor-pseudoephedrine and norephedrine giving amphetamine-like action (Patel,
2000).
Drug interactions are a specific category of adverse drug reactions, which occur when a food,
supplement, herb, clinical drug, or illicit substance
affects the therapeutic response of a clinical drug
when taken concomitantly (Abbott et al., 2019).
When any combinations of these could lead to
undesired change in the condition of the patient
then that interaction is of potential clinical significance. Drug interactions can be classified as: drugdisease, herb-drug interactions (HDIs), drug-drug,
http://jppres.com/jppres
food-drug, supplement-drug, alcohol-drug, tobacco-drug, and illicit substance-drug interactions
(Abbott., 2019). The drug-disease interaction is
associated in patient suffering from any disease
such as renal or hepatic impairment, aplastic anemia, asthma, cardiac arrhythmia, diabetes mellitus,
epilepsy hypothyroidism etc. If the patient uses
drug and herb concomitantly then there are chances of drug–herb interaction as both contain pharmacological active compounds (Izzo, 2012). Drugdrug interaction occurs between two clinical drugs
like ciprofloxacin taken with antacids (Bedada et
al., 2015). There are other examples of interaction
of drug with dietary supplements, food, beverages, cigarette etc. For example, vitamin K and anticoagulants like warfarin, theophylline, and tobacco (Bedada et al., 2015).
When interactions occur between khat and clinical drugs, it can be caused by either pharmacokinetic (PK) or pharmacodynamic mechanisms.
While pharmacodynamic interactions could contribute to adverse interactions, pharmacokinetic
interactions can occur at any point during absorption, distribution, metabolism, and excretion
(ADME). Drug-metabolizing enzymes and drugtransporters play crucial roles in the ADME of
xenobiotics, including clinical drugs or illicit substances (Abbott et al., 2019). Khat-drug interactions are based on alteration of the plasma concentrations of a victim drug or its metabolites due to
khat causing inhibition and/or induction of the
metabolizing enzymes like cytochrome P-450 system and drug transporters or interference and
changes the absorption, distribution, metabolism,
protein binding, or excretion of a victim drug (Lim
et al., 2019).
J Pharm Pharmacogn Res (2021) 9(3): 335
Albaser et al.
Khat-drug interactions: A systematic review
MATERIAL AND METHODS
Study design
Identification
This study was conducted as a systematic review. Electronic literature searches were made in
Google search engine to access publications from
databases like PubMed, Google Scholar, and
Cochrane using the keywords ‘khat’, ‘Catha edulis’
in combination with the terms ‘drug interaction’,
‘adverse-effects’, ‘side effects’, ‘adverse drug reaction’, ‘safety’, and ‘toxicity’. The search included
journals, reports, books, and related documents
published in English language were eligible for
inclusion. All preclinical and clinical reports on
interactions were read and relevant data were extracted by the first author into predefined tables
and validated by the second author. In vitro experiments, case reports and case series of possible
Cochrane Library
(n = 33)
PubMed
(n = 32)
interactions between khat and drugs were included. To limit the occurrence of undesirable articles,
these keywords and MeSH terms were searched in
the “Title/Abstract” category.
Selection criteria
To select the articles, the Rayyan web and mobile app for systematic reviews was used (Ouzzani
et al., 2016). 250 articles were identified, and then
the identified articles were checked in terms of
title, abstract, and content according to inclusion
and exclusion criteria. Finally, 18 articles were included in the study. The algorithm for the selection and filtering of articles is represented in Fig. 1.
The final selected articles were analyzed in detail
to assess the most current and relevant information about possible interactions between khat
(Catha edulis) and clinical drugs.
Google Scholar
(n = 184)
Additional record by
other sources (n = 1)
Records screened (n = 231)
Records excluded (no
relevant topic) (n = 208)
Eligibility
Full-text articles assessed for
eligibility (n = 23)
Full-text articles excluded,
with reasons (n = 5)
Included
Screening
Records after duplicates removed (n = 231)
Studies finally included (n =18)
Clinical (n=14)
Preclinical (n=4)
Figure 1. The criteria and the number of entry and exit articles.
http://jppres.com/jppres
J Pharm Pharmacogn Res (2021) 9(3): 336
Albaser et al.
RESULTS AND DISCUSSION
The findings of the search on khat and clinical
drugs interactions did not identify any review assessing the interaction between khat and clinical
drug. Based on the results from studies, it was
found that khat interacts with the following medications (Table 2).
Antibacterial drugs
Khat has been shown to reduce the bioavailability of antibiotics such as ampicillin, amoxicillin,
cephradine, ciprofloxacin and tetracyclines (Abbott et al., 2019). Omer et al. (1997) reported a significant decrease in ampicillin bioavailability.
However, no effect was noted with amoxicillin.
The suggested explanation was that the tannins
might have complexed the antibiotics or by interfering with the gut absorption processes. Amphetamine-like compounds affect appetite centrally by
acting in the hypothalamus. Apart from its central
effect, cathinone enhances sympathomimetic activity leading to a delay in gastric emptying. In another study, the absorption of cephradine was reduced by 50%, when has been taken concomitantly
with khat (Kassem, 2004). Tetracycline-khatinteraction has been evaluated both in vitro and in
vivo. In vitro studies have indicated a statistically
significant interaction between tetracycline and
khat. Such interaction may be attributed to possible complexation between tetracycline and certain
khat constituents, such as polyvalent cations, calcium, magnesium, iron, cadmium, lead, copper,
and zinc or possible complexation and/or adsorption of tetracycline-HCl with and/or onto tannic
acid. Other possible complexation may also occur
with other khat constituents such as cathinone,
cathine and pseudoephedrine. On the other hand,
it was consistent with the in vitro findings. In vivo,
khat chewing significantly reduces most pharmacokinetics parameters, which reflect reduction in
the rate and extent of tetracycline absorption,
which may be attributed to the same causes we
mentioned above. The same study reported a significant reduction in a half-life and the elimination
rate constant of tetracycline. This reduction occurs
due to possible enhancement of renal excretion
http://jppres.com/jppres
Khat-drug interactions: A systematic review
rate, perhaps by possibly urinary pH modification
by certain khat constituents and/or possible enhancement of tetracycline metabolism via enzyme
induction by one or more khat constituents (Farah
et al., 2015). A recent study has shown ciprofloxacin-khat interaction that the reduction in pharmacokinetics parameters of ciprofloxacin. The result
attributed to the same reasons previously mentioned (Al-Mekhlafi, 2020).
Antimalarial drugs
In Yemen, it was reported that the coadministration of chloroquine (CQ) and khat was
found to significantly affects the pharmacokinetics
of CQ among both healthy controls and malaria
patients and significantly reduces plasma CQ concentrations in malaria patients (Issa et al., 2016). At
therapeutic concentration, chloroquine is metabolized into desethylchloroquine primarily by
CYP2C8 (60%) followed by CYP3A4 (25%), and
CYP2D6 is a high affinity but with significantly
low-capacity enzyme to metabolize chloroquine
(Projean et al., 2003). Furthermore, a previous
study reported no significant inhibition of CYP2D6
by chloroquine in human (Masimirembawa et al.,
1996). Thus, khat-chloroquine interaction reported
by Issa et al. (2016), may not be at the CYP2D6
level. Nevertheless, concomitant khat use may
compromise the antimalarial activity of primaquine. Indeed, a significant association of lowactivity CYP2D6 phenotypes with the initial relapse and number of malaria relapses was reported (Bennett et al., 2013). Therefore, khat abstinence
while on treatment with CYP2D6 substrate drugs
is advisable (Bedada et al., 2018).
Antiplatelet drugs
Noman and Kadi (2012), in their study in
healthy volunteers suggested that khat chewing
had a worse effect on the bioavailability and
pharmacokinetic properties of aspirin. A significant reduction of bleeding time was observed in
khat chewers who were taking aspirin (100 mg
daily) on a long-term basis compared with nonkhat chewers taking the same dose of aspirin. This
finding suggested that constituents of khat attenuate the antiplatelet aggregating properties of aspiJ Pharm Pharmacogn Res (2021) 9(3): 337
Albaser et al.
rin, and thereby neutralize the beneficial actions of
aspirin (Alkadi et al., 2008). Alhazmi et al., 2020,
reported a significant influence of khat on the peak
ratio of clopidogrel (CLOP) metabolite, which was
found to be significantly decreased in comparison
to CLOP alone, suggesting a significant decrease in
the conversion of CLOP to its active metabolite
due to the inhibition of CYP450 enzymes by khat.
Therefore, there might be a need for dose adjustment for regular khat chewers using CLOP.
CNS drugs
Elkady et al. (2020) reported that coadministration of khat with some CNS drugs
(clomipramine, vilazodone, aripiprazole, and sertraline) significantly increase their bioavailability
in rats, which attributed to the inhibition of their
metabolic enzymes CYP450, CYP2D6 and CYP3A4
isoforms by khat.
Anesthetic drugs
Khat has been shown to reduce the effects of a
local anesthetic drug, benoxinate (oxybuprocaine)
(Abbott et al., 2019). Khat consumption decreases
pain threshold and affects patients' comfort during
local anesthesia and during surgery in routine cataract surgery (Bamashmus et al., 2010). The effect
of khat on general anesthetics was reported by
Bamgbade, in Manchester, he noticed the effect of
khat consumption on three cases that had general
anesthesia and he recommended that optimal
perioperative care of khat users requires careful
titration of cardiostable anesthetic and comprehensive monitoring (Bamgbade, 2008). However,
Mion (2017) observed that the interaction between
khat and general anesthesia was not what was
commonly believed (the popular perception that
patients who chronically ingest amphetamine or
amphetamine-like drugs will require high doses of
anesthetic drugs to achieve adequate analgesia,
sedation, and anesthesia) (Johnston et al., 1972).
Neuroleptics drugs
In addition to psychological adverse effects
such as psychosis and exacerbation of pre-existing
psychotic disorder, khat interacts with antipsychotic drugs such as haloperidol and risperidone
http://jppres.com/jppres
Khat-drug interactions: A systematic review
leading to attenuates all used treatment medications, aggravates the disease symptoms, and deteriorates all biochemical markers of the patients. So
that khat chewing in schizophrenic patients is contraindicated (Weli and El-Shaibany, 2011; Kotb ElSayed and Amin, 2015)
Alteration the metabolizing enzymes activity by
khat
The modulation in the activity of CYPs and
drug transporters by herbal products may influence the oral bioavailability, which alters the blood
levels of affected drug (Brown et al., 2008). Inhibition of drug metabolizing enzymes is considered
the most common mechanism underlying PK
drug–drug interactions and HDIs (Wienkers and
Heath, 2005). In vitro, a current study carried by
Lim et al. (2019) reported that khat-drug interactions were possible due to administration of clinical drugs metabolized by CYP2C9/CYP2D6/
CYP3A4 together with khat chewing and recommended further in vivo studies are required to confirm their findings and identify the causative constituents of these inhibitory effects. This recent
study investigated inhibitory potencies of khat
ethanol extract and its major active constituent
cathinone on the major CYP enzymes, CYP2C9,
CYP2D6, and CYP3A4 involved in phase I drug
metabolism. The CYP450 enzymes are susceptible
to inhibition or induction by natural products including herbal medicines that contain mixture of
phytochemicals (Delgoda and Westlake, 2004;
Wanwinmolruk and Prachayasittikul, 2014; Cho
and Yoon, 2015). Chronic use of khat is associated
with a variety of mental and personality disorders
that require treatment and CYP2D6 metabolizes
several psychoactive drugs including psychotropic, anti-depressants and antipsychotics (Bedada et al., 2018). Considerable inhibition of
CYP2D6 by khat use may result in unanticipated
adverse events and/or treatment failures. CYP2D6
is constitutively expressed in human brain, where
it is involved in endogenous metabolism including
dopamine and serotonin (Bedada et al., 2018).
Cathinone increases the levels of dopamine in the
brain, possibly by acting on the catecholaminergic
synapses.
J Pharm Pharmacogn Res (2021) 9(3): 338
Albaser et al.
Khat-drug interactions: A systematic review
Table 2. Some selected khat-drug interactions.
No.
Type of study
Drug Category
Drug
Mechanism of action of the drug
Mechanism of interaction
with khat
Outcome
Reference
1
Clinical and basic (8
healthy adult male)
Antibiotic
Ampicillin
Acts as an irreversible inhibitor of
the enzyme transpeptidase,
which is needed by bacteria to
make the cell wall.
Reduce bioavailability
Urine level
Omer et al.,
1997
2
Clinical and basic (8
healthy adult male)
Amoxicillin
As above
Reduced the extent of
amoxicillin absorption
Urine level
Ghani et al.,
1999
3
Clinical and basic (10
healthy adult male)
Tetracycline
Protein synthesis inhibitors.
Formation of nonabsorbable complex with
polyvalent cations, such as
calcium, magnesium, iron,
cadmium, lead, copper,
and zinc. Delayed in
gastric emptying. Prolong
resident time in stomach
leading to formation of
epitetracycline the less
antimicrobial activity
Blood level
Farah et al.,
2015
4
Clinical and basic (8
healthy adult male)
Cephradine
Inhibits bacterial cell wall
synthesis in a manner similar to
that of penicillin
Reduce bioavailability
Urine level
Kassem, 2004
5
Clinical and basic (8
healthy adult male)
Ciprofloxacin
Inhibiting a type II topoisomerase
(DNA gyrase) and topoisomerase
IV, necessary to separate bacterial
DNA, thereby inhibiting cell
division
Reduce bioavailability
Plasma level
Al-Mekhlafi,
2020
6
Prospective clinical trial
(323 patients
undergoing cataract)
Local anesthetic
Benoxinate
(oxybuprocaine)
Reversible block, competitive
inhibition of Ach, decreased
membrane permeability to Na+
influx
Decreases pain threshold
Pain score cart (pain
experience during injection,
intraoperatively, and
postoperatively)
Bamashmus et
al., 2010
7
Clinical report (three
adult patients)
General
anesthetic
Optimal perioperative care
of khat users requires
Observational
Bamgbade, 2008
8
Clinical and basic (15
healthy adult male and
103 patients)
Antimalarial
drug
Chloroquine
The drug concentrates in the
acidic food vacuole of the
parasite and interferes with
essential processes
Reduce bioavailability
Plasma level, parasite
clearance
Issa et al., 2016
9
Clinical and basic (28
healthy adult male)
Antiplatelet
Aspirin
Aspirin is non-selective and
irreversibly inhibits COXs
Attenuate the antiplatelet
aggregating properties of
aspirin
Urine level
Noman and
Kadi, 2012
http://jppres.com/jppres
J Pharm Pharmacogn Res (2021) 9(3): 339
Albaser et al.
Khat-drug interactions: A systematic review
Table 2. Some selected khat-drug interactions (continued…)
No.
Type of study
Drug Category
Drug
10
Clinical and basic (74
healthy adult male)
Antiplatelet
Aspirin
11
Pre-clinical (eighteen
rats)
12
Clinical trial (170
asthmatic patients)
13
Pre-clinical (twenty-four
C57BL/6J WT and
twelve DAT-Cnr2 cKO
mice)
14
Pre-clinical (rats)
15
Clinical trial (69 patients)
16
Clinical trial (37 healthy
adult male and 42
paranoid shazo
Haloperidol,
risperidone
17
Preclinical in vitro
Clinical drugs
metabolize by
CYP2C9, CYP2D6
and CYP3A4
18
Clinical and basic (63
healthy adult male)
Drugs metabolize by
CYP2D6
Mechanism of action of the drug
Mechanism of interaction
with khat
Outcome
Reference
BT, CT, PT, PTT, PC and BF
Alkadi et al.,
2008
Clopidogrel
Inhibits the binding of adenosine
diphosphate (ADP) to its platelet
P2Y12 receptor
Inhibition of CYP450
enzymes by khat
CYP450 enzymes activity
Alhazmi et al.,
2020
Salbutamol
β2 agonist
Improve the salbutamol
effects
Frequent, asthmatic
symptoms, FEV1%, PEFR%
Yitna et al., 2018
JWH-133
CB2R agonist
Interact with khat extractmediated locomotor effects
Locomotor, activity test,
immunohistochemistry,
reverse transcriptase
polymerase chain reaction
technique
Geresu et al.,
2019
CNS drugs
Clomipramine,
vilazodone,
aripiprazole,
sertraline
A tricyclic antidepressant, a
serotonin partial agonist-reuptake
inhibitor (SPARI), an
antipsychotic, a type of
antidepressant known as a
selective serotonin reuptake
inhibitor (SSRI), respectively
Khat significantly increase
bioavailability of these
drugs, which might be
attributed to inhibition of
their metabolic enzymes
CYP450, CYP2D6 and
CYP3A4 isoforms
Neuroleptics
Haloperidol,
risperidone
A first-generation (typical
antipsychotic)
Reduce the effectiveness of
drugs and increase the
frequency of relapse
Anti-asthmatic
Elkady et al.,
2020
Clinical observational study
Weli and ElShaibany, 2011
DOPAC, homovanillic acid,
serotonin 5hydroxyindoleacetic acid,
epinephrine, norepinephrine
Kotb El-Sayed
MI and Amin;
2015
Inhibit CYP2C9, CYP2D6
and CYP3A4
CYP 450 enzymes activity
Lim et al., 2019
Inhibit CYP2D6
CYP 450 enzymes activity
Bedada et at.,
2018
JWH-133: A potent selective CB2 receptor agonist; CB2R: Cannabinoid receptor type 2; FEV1%: Forced expiratory volume in one second; PEFR: Peak expiratory flow rate; BT: Bleeding time; CT: Clotting time; PT: Prothrombin
time; PTT: Partial thromboplastin time; PC: Platelets count; BF: Blood film; C57BL/6J WT and DAT-Cnr2 cKO mice: mutant mice.
http://jppres.com/jppres
J Pharm Pharmacogn Res (2021) 9(3): 340
Albaser et al.
A previous clinical study suggested that
CYP2D6 slow metabolizers might have a higher
dopamine tone in the pituitary (Bedada et al.,
2018) and the inhibition of CYP2D6 activity in the
brain may be another mechanism by which cathinone, the main psychostimulant alkaloid in khat,
increases the levels of dopamine in the brain.
Possible khat potential therapeutic interactions
Yitna et al. (2018) have reported that apart from
its psycho stimulating prosperities, khat has moderate potential benefit for the improvement of episodes of an asthma attack and reduction of asthmatic symptoms. This study showed that khat
chewer asthmatic patients had relatively better
peak expiratory flow rate and also relatively lesser
recurrent night-time awake due to an asthmatic
attack. The possible explanation for this finding
could be the effect of khat through its constituents
upon activation of α2 and 5HT7 receptors and inhibition of ACh thereby modulating airway smooth
muscle contraction (Freud-Michel et al., 2008). The
results by Geresu et al. (2019) suggested the CB2Rs
selectively interact with khat extract-mediated
locomotor effects and could be utilized as therapeutic target in central nervous system movement
disorders associated with dopamine dysregulation.
Limitations
The present review has several limitations that
must be acknowledged with the regard of interpreting the findings. The number of databases
searched was more modest and a language constraint was also applied, so that there might be
several publications that were ignored. As the selection and assessment criteria were established
based on the authors’ subjunctives points of views,
the quality of the included studies may not be appraised appropriately. In addition, the selected
articles included different study types not only
clinical trials, but preclinical studies involved in
vitro and in vivo. Another limitation was that the
review concentrated on the interaction of khat
with clinical drugs and excluded the articles evalhttp://jppres.com/jppres
Khat-drug interactions: A systematic review
uated the interactions of khat with alcohol and
tobacco and illicit substances.
Future perspectives
Despite the above observations, the literature
reviewed is associated with a few shortcomings,
suggesting the need for further research and documentation on this area of knowledge. Further
clinical studies are recommended to thoroughly
investigate the interaction of khat with clinical
drugs.
CONCLUSIONS
The study concluded that khat use significantly
interact with most clinical drugs and may cause
unpredictable pharmacological sequences. Healthcare providers should recommend their patients to
stop khat chewing during medication process. The
study recommended conducting more studies,
which are very important for investigation the
khat-clinical drugs interactions especially with
chronic used drugs. It is recommended that, in the
interim, healthcare providers should be more familiar with the known and suspected adverse
khat-drug interactions to optimally serve their
patients who chew khat.
CONFLICT OF INTEREST
The authors declare no conflicts of interests.
ACKNOWLEDGMENTS
This research was not funded and did not receive any specific grants from funding agencies in the public, commercial,
or non-profit sectors.
REFERENCES
Abbott KL, Flannery PC, Gill KS, Boothe DM, Dhanasekaran
M, Mani S, Pondugula SR (2019) Adverse
pharmacokinetic interactions between illicit substances
and clinical drugs. Drug Metab Rev 52(1): 44–65.
Alhazmi HA, Kadi AA, Attwa MW, Ahsan W, Taha MME,
Khalid A (2020) Exploring the effect of khat (Catha edulis)
chewing on the pharmacokinetics of the antiplatelet drug
clopidogrel in rats using the newly developed LCMS/MS technique. Open Chem 18: 681–690.
J Pharm Pharmacogn Res (2021) 9(3): 341
Albaser et al.
Khat-drug interactions: A systematic review
Al-Juhaishi, T, Al-Kindi S, Gehani A (2012) Khat: A widely
used drug of abuse in the horn of Africa and the Arabian
Peninsula: review of literature. Qatar Med J 2012(2): 1–6.
Farah HF, Attef AO, Ali AA (2015) The influence of khat on
the in-vitro and in-vivo availability of tetracycline-HCl.
Res J Pharma Dosage Forms Tech 7(1): 1–6.
Alkadi HO, Al-Kamarany M, Al-Kadi H, Lyoussi B, Khalil KA
(2008) Khat–aspirin interaction. Yemen J Pharm Biol Sci 2:
32–39.
Freund-Michel VC, Patel HJ, Birrell MA, Murray-Lyon IM,
Belvisi MG (2008) Modulation of cholinergic contractions
of airway smooth muscle by cathinone: potential
beneficial effects in airway diseases. Eur Respir J 32: 579–
584.
Al-Mekhlafi AG (2020) The effect of chewing khat on drug
absorption: A case study of pharmacokinetic profiles of
ciprofloxacin 500 mg tablets. Int J Pharm Pharm Res 18(4):
415–428.
Balint EE, Falkay G, Balint GA (2009) Khat: A controversial
plant. A review. Wien Klin Wochenschr 121: 604–614.
Bamashmus M, Othrob NY, Mousa A, Al-Tay W (2010) Effect
of khat (qat) consumption on pain during and after local
anesthesia for patients undergoing cataract surgery. Med
Sci Monit 16(8): SR29–33.
Bamgmade OA (2008) The perioperative implications of khat
use. Eur J Anaesthesiol 25(2): 170–172.
Bedada W, de Andres F, Engidawork E, Hussein J, Lerena A,
Aklillu E (2018) Effects of khat (Catha edulis) use on
catalytic
activities
of
major
drug-metabolizing
cytochrome P450 enzymes and implication of
pharmacogenetic variations. Sci Rep 8: 12726.
Bedada W, de Andres F, Engidawork E, Pohanka A, Beck O,
Bertilsson L, Llerena A, Aklillu E (2015) The
psychostimulant khat (Catha edulis) inhibits CYP2D6
enzyme activity in humans. J Clin Psychopharmacol
35(6): 694–699.
Bennett JW, Pybus BS, Yadava A, Tosh D, Sousa JC, McCarthy
WF, Deye G, Melendez V, Ockenhouse CF (2013)
Primaquine failure and cytochrome P-4502D6 in
Plasmodium vivax malaria. N Engl J Med 369: 1381–1382.
Bogale T, Engidawork E, Yisma E (2016) Subchronic oral
administration of crude khat extract (Catha edulis Forsk)
induces schizophrenic-like symptoms in mice. BMC
Complement Altern Med 16: 153.
Brown L, Heyneke O, Brown D, van Wyk JP, Hamman JH
(2008) Impact of traditional medicinal plant extracts on
antiretroviral drug absorption. J Ethnopharmacol 119:
588–592.
Cho HJ, Yoon IS (2015) Pharmacokinetic interactions of herbs
with cytochrome p450 and p-glycoprotein. Evid Based
Complement Alternat Med 2015: 736431.
Cupp MJ (1999) Herbal remedies: Adverse effects and drug
interactions. Am Fam Physician 59 (5): 1239–1245.
Delgoda R, Westlake AC (2004) Herbal interactions involving
cytochrome p450 enzymes: a mini-review. Toxicol Rev 23:
239–249.
Elkady E, Fouad MA, Alshoba N, Tarek S (2020) Validated
LC-MS/MS method for the determination of some
prescribed CNS drugs: Application to an in vivo
pharmacokinetic
study of
drug-herb
metabolic
interaction potential of khat. Microchem J 158: 105261.
http://jppres.com/jppres
Geresu B, Canseco-Alba A, Sanabria B, Lin Z, Liu QR, Onaivi
ES, Engidawork E (2019) Involvement of CB2 receptors in
the neurobehavioral effects of Catha edulis (Vahl) Endl.
(khat) in mice. Molecules 24: 316.
Ghani YMA, Etman MA, Nada AH (1999) Effect of khat
chewing on the absorption of orally administered
amoxicillin. Acta Pharm (Croatia) 49(1): 43–50.
Hussain MS (2011) Patient counseling about herbal-drug
interactions. Afr J Tradit Complement Altern Med 8: 152–
163.
Issa FH, Al-Habori M, Chance ML (2016) Effect of khat (Catha
edulis) use on the bioavailability, plasma levels and
antimalarial activity of chloroquine. Sultan Qaboos Univ
Med J 16: e182–188.
Izzo AA (2012) Interactions between herbs and conventional
drugs: Overview of the clinical data. Med Princ Prac 21:
404–428.
Johnston RR, Way WL, Miller RD (1972) Alteration of
anesthetic requirement by amphetamine. Anesthesiology.
36: 357–363.
Kassem YAA (2004) Cephradine bioequivalence and its
interaction with khat and food (Al-Sayadeyah) in Yemen.
Master Thesis.
Kotb El-Sayed MI, Amin HK (2015) Catha edulis chewing
effects on treatment of paranoid schizophrenic patients.
Neuropsychiatr Dis Treat 11: 1067–1076.
Lim SYM, Azidin ARB, Ung YT, Al-Shagga M, Alshawsh MA,
Mohamed Z, Ong CE, Pan Y (2019) Effect of 95% ethanol
khat extract and cathinone on in vitro human recombinant
cytochrome p450(cyp) 2c9, cyp2d6, and cyp3a4 activity.
Eur J Drug Metab Pharmacokinetic 44(3): 423–431.
Masimirembwa CM, Gustafsson LL, Dahl ML, Abdi YA,
Hasler JA (1996) Lack of effect of chloroquine on the
debrisoquine (CYP2D6 and S-mephenytoin (CYP2C19)
hydroxylation phenotypes. Br J Clin Pharmacol 41: 344–
346.
Mion G (2017) Chronic amphetamine users do not need more
drugs during general anesthesia. Anesth Analg 124(6):
2092–2093.
Noman MA, Kadi HO (2012) In vitro and in vivo evaluation of
acetylsalicylic acid in khat (qat) chewing healthy
volunteers. J Clin Med Res 4(4): 53–58.
Nyongesa WA (2013) Mechanism of action of cathinone from
khat (Catha edulis) on behavioural and reproductive
function in vervet monkey (Chlorocebus aethiops). PhD
Thesis.
J Pharm Pharmacogn Res (2021) 9(3): 342
Albaser et al.
Khat-drug interactions: A systematic review
Omer AA, Abdul-Azem A, Hassan MA (1997) Effect of khat
chewing on the bioavailability of ampicillin and
amoxycillin. J Antimicrobial Chemother 39: 523–525.
Wanwimolruk S, Prachayasittikul V (2014) Cytochrome P450
enzyme mediated herbal drug interactions (Part 1).
EXCLI J 13: 347–391.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A
(2016) Rayyan — a web and mobile app for systematic
reviews. Syst Rev 5: 210.
Weli AM, El-Shaibany A (2011) Interference of khat with
treatment of paranoid schizophrenia. Int J Chem Pharm
Sci 2(1): 1–11.
Patel NB (2000) Mechanism of action of cathinone: The active
ingredient of khat (Catha edulis). East Afr Med J 77(6):
329–332.
Wienkers LC, Heath TG (2005) Predicting in vivo drug
interactions from in vitro drug discovery data. Nat Rev
Drug Discov 4: 825–833.
Projean D, Baue B, Farintti R, Flinois JP, Beaune P, Taburet
AM, Ducharme J (2003) In vitro metabolism of
chloroquine: Identification of CYP2C8, CYP3A4, and
CYP2D6 as the main isoforms catalyzing Ndesethylchloroquine formation. Drug Metab Dispos 31:
748–754.
Wondemagegn AT, Cheme MC, Kibret KT (2017) Perceived
psychological, economic, and social impact of khat
chewing among adolescents and adults in Nekemte
Town, East Welega Zone, West Ethiopia. BioMed Res Int
2017: 7427892.
Yitna E, Mossie A, Yami A (2018) Effects of khat (Catha edulis)
on bronchial asthma. Open J Asthma 2(1): 5–10.
_________________________________________________________________________________________________________
AUTHOR CONTRIBUTION:
Contribution
Albaser NA
Mohamad AWH
AL-Kamarany MA
Concepts or ideas
x
x
Design
x
Definition of intellectual content
x
x
Literature search
x
x
Experimental studies
x
Data acquisition
x
Data analysis
x
x
x
x
Statistical analysis
Manuscript preparation
x
x
Manuscript editing
x
x
Manuscript review
x
x
x
Citation Format: Albaser NA, Mohamad AWH, AL-Kamarany MA (2021) Khat-drug interactions: A systematic review. J Pharm Pharmacogn
Res 9(3): 333–343.
http://jppres.com/jppres
J Pharm Pharmacogn Res (2021) 9(3): 343